Clinical Trial Update: Iron in Congestive Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating iron therapy in patients with heart failure and iron deficiency anemia was terminated, as reported by the University of Ulm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Iron Deficiency Anemia

Snippet

Sponsor: University of Ulm | Conditions: Heart Failure, Iron Deficiency | Phase 3 | Status: TERMINATED